Auvelity - 2022's New Antidepressant Medication
Auvelity combines dextromethorphan and bupropion in a novel antidepressant formulation.

In this article
Auvelity (dextromethorphan/bupropion) For Depression
Auvelity is a medication newly released on the market in August of 2022. It is a combination of two common medications. It is dextromethorphan, which is used in a lot of cough medicines. The other active ingredient is bupropion which is an antidepressant and smoking cessation agent. The two are combined to create a greater antidepressant effect.
Dextromethorphan Mechanism of Action
The interesting thing about this medication is that it is the first time that dextromethorphan has been used to treat depression. Dextromethorphan has been used recreationally to create a “high.” It was this “high” combined with the increased popularity of Ketamine's use for depression that led to the increased interest in dextromethorphan. Dextromethorphan and Ketamine both act as an antagonist (blocker) of the NMDA receptor. Blockade of the NMDA receptor is what is believed to create the antidepressant effects from Ketamine. Dextromethorphan takes advantage of this mechanism of action without ketamine's side effects.
Benefits of Dextromethorphan vs Ketamine
Ketamine has a lot of drawbacks to it. It must be administered through an IV and can have some major side effects. Some of the side effects of Ketamine include amnesia, psychosis, visual distortions, and confusion. The side effect profile of dextromethorphan is vastly superior in comparison. Dextromethorphan is not a controlled substance unlike Ketamine. Ketamine is a schedule III-controlled substance. This puts Ketamine as having a higher addictive potential than drugs like Xanax or Tramadol.
Bupropion Mechanism of Action
Bupropion acts as Norepinephrine-Dopamine Reuptake Inhibitor. It increases the levels of dopamine and norepinephrine in the synaptic cleft. The synaptic cleft is the space between two neurons. The level of chemicals in this space is what determines mood and other functions of the body. Bupropion has been specifically shown to help with conditions like Seasonal Affective Disorder and Major Depressive Disorder. It does not help with anxiety disorders and may make them worse.
Auvelity Side Effects
Side effects of dextromethorphan/bupropion include:
- dizziness
- headache
- diarrhea
- somnolence
- dry mouth
- sexual dysfunction, and
- hyperhidrosis (Excess sweating)
The Anxious Resistance Take on the New Antidepressant
Auvelity is an interesting medication. The combination of bupropion with dextromethorphan shows greater effectiveness than bupropion alone. Using the NMDA receptor actions of dextromethorphan may increase the benefits of this medication. It is a novel mechanism that only a few drugs currently used to treat depression take advantage of. It is worth asking the question of why a formulation of dextromethorphan alone is not available. The potential of dextromethorphan alone should justify its use in this manner. Using bupropion with dextromethorphan is a bit of a mystery. Combination therapies are common in the psychiatric space, however this one does not seem to make a lot of sense. It may hold potential benefits over other medications by using the mechanism in dextromethorphan. Though I believe there would have been more benefit in developing a dextromethorphan formulation for depression without the bupropion combination.
